Design Therapeutics, Inc. (DSGN) Q4 2023 Earnings Call Transcript
Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Results Conference Call March 19, 2024 4:30 PM ET Company Participants Sean Jeffries – COOPratik Shah – Chairman, CEO Conference Call Participants Joseph Schwartz – Leerink PartnersLaura Chico – Wedbush Operator Good afternoon, and welcome to Design’s Conference Call. [Operator Instructions]. Please be advised that this call is being…